Statements (16)
Predicate | Object |
---|---|
gptkbp:instanceOf |
probiotic formulation
|
gptkbp:administeredBy |
oral formulation
|
gptkbp:clinicalTrialPhase |
Phase 2
|
gptkbp:contains |
gptkb:Limosilactobacillus_reuteri
glycerol dextran microparticles |
gptkbp:developedBy |
Scioto Biosciences
|
gptkbp:effect |
potential improvement in social functioning
|
https://www.w3.org/2000/01/rdf-schema#label |
Sb-121
|
gptkbp:intendedUse |
gptkb:autism_spectrum_disorder
|
gptkbp:mechanismOfAction |
modulation of gut microbiome
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:studiedIn |
clinical trials
|
gptkbp:targetAudience |
children and adolescents with autism
|
gptkbp:bfsParent |
gptkb:сурьма
|
gptkbp:bfsLayer |
7
|